Insight, analysis, and practical IP commentary.

Understanding the Patent Cliff: Its Role in Biopharmaceutical Innovation and Market Dynamics

The U.S. biopharmaceutical sector faces cyclical revenue challenges known as the patent cliff, where multiple high-revenue drugs lose exclusivity simultaneously, opening markets to generics and biosimilars. This phenomenon, while causing sharp revenue declines, is integral to the innovation cycle—spurring companies to…